IRIS UniCatt

Bentivoglio, Anna Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.335
NA - Nord America 7.833
AS - Asia 3.764
SA - Sud America 612
AF - Africa 96
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 20.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.744
DE - Germania 2.793
CN - Cina 1.427
SE - Svezia 1.317
SG - Singapore 1.243
IT - Italia 947
UA - Ucraina 849
FR - Francia 635
BR - Brasile 547
IE - Irlanda 463
GB - Regno Unito 367
FI - Finlandia 276
ID - Indonesia 275
RU - Federazione Russa 250
IN - India 237
HK - Hong Kong 167
TR - Turchia 147
NL - Olanda 90
BE - Belgio 75
CI - Costa d'Avorio 67
KR - Corea 59
AT - Austria 57
PL - Polonia 53
CA - Canada 49
JP - Giappone 44
IR - Iran 38
ES - Italia 27
MX - Messico 25
CZ - Repubblica Ceca 23
CH - Svizzera 20
IL - Israele 20
AR - Argentina 18
AU - Australia 18
RO - Romania 14
BD - Bangladesh 12
EC - Ecuador 12
EU - Europa 12
LT - Lituania 12
UZ - Uzbekistan 10
VN - Vietnam 10
BO - Bolivia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
CL - Cile 8
KE - Kenya 8
PA - Panama 8
PK - Pakistan 8
CO - Colombia 7
DK - Danimarca 7
EE - Estonia 7
GR - Grecia 7
HU - Ungheria 7
IQ - Iraq 7
PT - Portogallo 7
LU - Lussemburgo 6
MA - Marocco 6
EG - Egitto 5
KZ - Kazakistan 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
KG - Kirghizistan 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
TW - Taiwan 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HN - Honduras 3
JO - Giordania 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
AM - Armenia 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TM - Turkmenistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
Totale 20.674
Salva come PNG Salva come JPEG
Città #
Chandler 1.550
Singapore 748
Ashburn 730
Dublin 460
Jacksonville 451
San Mateo 368
Nanjing 293
Ann Arbor 274
Jakarta 273
Wilmington 243
Dearborn 183
Boston 172
New York 158
Milan 153
Woodbridge 151
Munich 150
Rome 144
Lawrence 140
Nürnberg 137
Moscow 129
Houston 126
Cattolica 122
Izmir 117
Marseille 116
Beijing 106
Redwood City 102
Seattle 101
Lancaster 99
Princeton 95
Boardman 94
Redmond 89
Nanchang 88
Helsinki 84
Fairfield 82
Shenyang 74
The Dalles 73
Chicago 70
Brussels 68
Abidjan 67
Norwalk 64
Los Angeles 60
Hebei 58
Hefei 56
Jiaxing 56
Mountain View 54
Frankfurt am Main 52
Hangzhou 51
Seoul 51
University Park 51
Pune 49
Bremen 45
Tianjin 45
Changsha 44
Hong Kong 44
Kunming 42
São Paulo 42
Warsaw 41
Leawood 38
London 36
Shanghai 35
Nuremberg 34
Vienna 33
Guangzhou 32
Trieste 32
Zhengzhou 32
Fremont 29
Düsseldorf 26
North Bergen 25
Simi Valley 24
Washington 24
Augusta 23
Toronto 23
Cambridge 21
Falkenstein 21
Falls Church 20
Andover 18
Jinan 18
Brno 16
Lappeenranta 16
Lauterbourg 16
Portsmouth 16
Amsterdam 15
Brasília 15
Kish 15
Busto Arsizio 13
Detroit 13
Paris 13
San Diego 13
Council Bluffs 12
Edinburgh 12
Ningbo 12
Rio de Janeiro 12
Columbus 11
Fuzhou 11
Belo Horizonte 10
Lanzhou 10
Madrid 10
Ottawa 10
Phoenix 10
Zurich 10
Totale 10.420
Salva come PNG Salva come JPEG
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 328
The role of small intestinal bacterial overgrowth in Parkinson's disease 191
Heart Rate Variability during wake and sleep in Huntington's Disease patients. An observational, cross-sectional, cohort study 188
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 166
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 162
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 158
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 150
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 146
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches 143
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 142
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 141
Mutation screening of the DYT6/THAP1 gene in Italy 141
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 138
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 138
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 136
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 135
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 134
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 134
Emotional Awareness, Relationship Quality, and Satisfaction in Patients With Parkinson's Disease and Their Spousal Caregivers 134
Assessment of neurological manifestations in hospitalized patients with COVID-19 133
Patient's Loss of Empathy Is Associated With Caregiver Burden 132
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 131
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 130
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 129
Dopaminergic agents and nutritional status in Parkinson's disease 129
Atrofia multisistemica: correlazioni tra caratteristiche cliniche, prove di reflettività cardiovascolare e reperti di risonanza magnetica 128
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 124
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment 123
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 122
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 119
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 119
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 118
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa responsive parkinsonism 116
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 116
Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms 114
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 113
Movement disorders in multiple sclerosis: Causal or coincidental association? 113
Clinical and genetic characteristics of late-onset Huntington's disease 113
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 113
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 112
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 111
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview 110
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 109
Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy 109
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 109
Dystonia gravidarum: a new case with a long follow-up 108
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 107
Analysis of blink rate in patients with blepharospasm 105
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families 105
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 104
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 104
Early DEtection of wEaring off in Parkinson disease: the DEEP study 103
Use of ACE-inhibitors and falls in patients with Parkinson's disease 103
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 101
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication 101
Tremor in primary adult-onset dystonia: prevalence and associated clinical features 101
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 101
New olfactometric findings in Parkinson's disease 101
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 100
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 100
Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA 100
Measuring gait quality in Parkinson’s disease through real-time gait phase recognition 100
Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature 100
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 99
Rapid Eye Movement Sleep Behavior Disorder: A Window on the Emotional World of Parkinson Disease, A Window on Dreaming 98
Reliability of Clinical Diagnosis of Dystonia 98
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 97
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 97
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 97
Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients 97
Impulsive compulsive behaviours in Parkinson's disease: patients' versus caregivers' perceptions 97
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 96
Tourettism in multiple sclerosis: a case report 96
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 95
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 95
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 95
Punding and computer addiction in Parkinson's disease 94
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 94
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 94
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 93
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 93
Abnormal gating of somatosensory inputs in essential tremor. 92
The long-term effect of tetrabenazine in the management of Huntington disease 92
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 92
DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7 92
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 92
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 91
Clinical differences between botulinum neurotoxin type A and B 91
PINK1 mutations are associated with sporadic early-onset parkinsonism. 91
Gastroenterologia. 90
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 90
Phenotypic characterisation of DYT13 primary torsion distonia. 89
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 89
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 88
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 88
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 87
Management of status dystonicus: our experience and review of the literature 87
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 86
Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease 86
Polysomnographic Findings and Clinical Correlates in Huntington Disease. A Cross-sectional Cohort Study. 86
Totale 11.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020503 0 0 0 0 0 0 0 0 0 0 292 211
2020/20211.972 118 214 31 218 257 78 229 55 249 116 368 39
2021/20222.127 187 214 58 116 110 67 38 313 81 152 327 464
2022/20234.473 521 587 354 602 337 527 238 351 642 90 160 64
2023/20242.312 85 659 77 158 90 307 145 151 34 67 252 287
2024/20253.671 103 170 408 152 382 198 207 253 761 431 606 0
Totale 21.005